Shionogi Fused Ring GLP-1 Receptor Agonist Patent Application
Summary
The USPTO published patent application US20260097037A1 by Shionogi & Co., Ltd. on April 9, 2026, covering fused ring compounds as GLP-1 receptor agonists for pharmaceutical use. The application was filed on September 21, 2023, under application number 19112403. The compounds are represented by formulas (I) and (II), with various substituents including phenyl groups and heterocyclic rings.
What changed
The USPTO published Shionogi & Co., Ltd.'s patent application covering fused ring compounds with GLP-1 receptor agonist activity, classified under CPC codes including C07D 471/04, C07D 471/18, and C07D 491/056. The compounds include formula (I) and (II) embodiments with substituents such as halogen, cyano, alkyl, and haloalkyl groups, with potential pharmaceutical applications.
For pharmaceutical companies and biotech firms developing GLP-1 based therapies, this published application establishes prior art as of September 2021. Competitors should conduct freedom-to-operate analyses to assess potential infringement risks. The patent claims covering fused ring GLP-1 agonists may affect product development strategies and patent filing timelines.
What to do next
- Monitor for patent issuance or examiner objections
- Review compound claims for freedom-to-operate analysis
Archived snapshot
Apr 11, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
FUSED RING COMPOUND HAVING GLP-1 RECEPTOR AGONIST EFFECT
Application US20260097037A1 Kind: A1 Apr 09, 2026
Assignee
Shionogi & Co., Ltd.
Inventors
Misato KITAMURA FUJIWARA, Yuji NISHIURA, Shomitsu MAENO, Hiroki KUSANO, Toshihiro WADA
Abstract
The present invention provides a compound represented by the following formula (I) or (II), or a pharmaceutically acceptable salt thereof. A compound represented by formula (I): whereinA1 is C(R1) or the like, R1 is a hydrogen atom or the like,R8 is a hydrogen atom or the like, B1 is CH or the like, R10 is cyano or the like, R3 is phenyl optionally substituted with substituent group F or the like,the substituent group F: halogen, cyano, alkyl, haloalkyl, alkyloxy, and haloalkyloxy,Q is a substituted or unsubstituted benzene ring or the like, R2 is substituted or unsubstituted alkyl or the like, and -L- is a group or the like shown below:
CPC Classifications
A61K 31/519 A61K 31/4184 A61K 31/4375 A61K 31/439 A61K 31/444 A61K 31/4725 A61K 31/4741 A61K 31/498 C07D 405/06 C07D 405/14 C07D 471/04 C07D 471/18 C07D 491/056 C07D 519/00
Filing Date
2023-09-21
Application No.
19112403
Related changes
Get daily alerts for USPTO Patent Applications - Organic Chemistry (C07D)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Organic Chemistry (C07D) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.